Kết quả tìm kiếm - Mohammad Atefi
- Đang hiển thị 1 - 15 kết quả của 15
-
1
Lactate, a Neglected Factor for Diabetes and Cancer Interaction Bằng Yong Wu, Yunzhou Dong, Mohammad Atefi, Yanjun Liu, Yahya Elshimali, Jaydutt V. Vadgama
Được phát hành 2016Revisão -
2
-
3
Proinflammatory Cytokines IL-6 and TNF-<i>α</i>Increased Telomerase Activity through NF-<i>κ</i>B/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Can... Bằng Seyung Chung, Yong Wu, Quincy Okobi, Debbie Adekoya, Mohammad Atefi, Orette Clarke, Pranabananda Dutta, Jaydutt V. Vadgama
Được phát hành 2017Artigo -
4
Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x–SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis Bằng Yong Wu, Xiaoting Yu, Xianghua Yi, Ke Wu, Sami Dwabe, Mohammad Atefi, Yahya Elshimali, Kevin T. Kemp, Kruttika Bhat, Jesse Haro, Marianna Sarkissyan, Jaydutt V. Vadgama
Được phát hành 2017Artigo -
5
Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma Bằng Mohammad Atefi, Earl Avramis, Amanda Lassen, Deborah J. Wong, Lídia Robert, David Foulad, Michael Cerniglia, Bjoern Titz, Thinle Chodon, Thomas G. Graeber, Begonya Comin-Anduix, Antoni Ribas
Được phát hành 2014Artigo -
6
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro Bằng Richard S. Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J. Cohen, Amrita J. Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst, Gerret Los, Dennis J. Slamon
Được phát hành 2009Artigo -
7
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma Bằng Mohammad Atefi, Bjoern Titz, Earl Avramis, Charles Ng, Deborah J. Wong, Amanda Lassen, Michael Cerniglia, Helena Escuin-Ordinas, David Foulad, Begonya Comin-Anduix, Thomas G. Graeber, Antoni Ribas
Được phát hành 2015Artigo -
8
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway Bằng Mohammad Atefi, Erika von Euw, Narsis Attar, Charles Ng, Connie Chu, Deliang Guo, Ramin Nazarian, Bartosz Chmielowski, John A. Glaspy, Begonya Comin-Anduix, Paul S. Mischel, Roger S. Lo, Antoni Ribas
Được phát hành 2011Artigo -
9
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma Bằng Deborah J. Wong, Lídia Robert, Mohammad Atefi, Amanda Lassen, Geetha Avarappatt, Michael Cerniglia, Earl Avramis, Jennifer Tsoi, David Foulad, Thomas G. Graeber, Begonya Comin-Anduix, Ahmed A. Samatar, Roger S. Lo, Antoni Ribas
Được phát hành 2014Artigo -
10
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress Bằng Jennifer Tsoi, Lídia Robert, Kim H.T. Paraiso, C. Galvan, Katherine M. Sheu, Johnson Lay, Deborah J. Wong, Mohammad Atefi, Roksana Shirazi, Xiaoyan Wang, Daniel Braas, Catherine S. Grasso, Nicolaos Palaskas, Antoni Ribas, Thomas G. Graeber
Được phát hành 2018Artigo -
11
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma Bằng Bjoern Titz, Anastasia Lomova, Allison Le, Willy Hugo, Xiangju Kong, Johanna ten Hoeve, Michael Friedman, Hubing Shi, Gatien Moriceau, Chunying Song, Aayoung Hong, Mohammad Atefi, Richard Li, Evangelia Komisopoulou, Antoni Ribas, Roger S. Lo, Thomas G. Graeber
Được phát hành 2016Artigo -
12
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines Bằng Erika von Euw, Mohammad Atefi, Narsis Attar, Connie Chu, Sybil Zachariah, Barry L. Burgess, Stephen Mok, Charles Ng, Deborah J. Wong, Bartosz Chmielowski, David I. Lichter, Richard C. Koya, Tara A. McCannel, Elena S. Izmailova, Antoni Ribas
Được phát hành 2012Artigo -
13
<i>BRAF</i> L597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors Bằng Kimberly B. Dahlman, Junfeng Xia, Katherine E. Hutchinson, Charles Ng, Donald Hucks, Peilin Jia, Mohammad Atefi, Zengliu Su, Suzanne Branch, Pamela L. Lyle, Donna J. Hicks, Viviana Bozón, John A. Glaspy, Neal Rosen, David B. Solit, James L. Netterville, Cindy L. Vnencak‐Jones, Jeffrey A. Sosman, Antoni Ribas, Zhongming Zhao, William Pao
Được phát hành 2012Artigo -
14
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) Bằng Poulikos I. Poulikakos, Yogindra Persaud, Manickam Janakiraman, Xiangju Kong, Charles Ng, Gatien Moriceau, Hubing Shi, Mohammad Atefi, Bjoern Titz, May Tal Gabay, Maayan Salton, Kimberly B. Dahlman, Madhavi Tadi, Jennifer A. Wargo, Keith T. Flaherty, Mark C. Kelley, Tom Misteli, Paul B. Chapman, Jeffrey A. Sosman, Thomas G. Graeber, Antoni Ribas, Roger S. Lo, Neal Rosen, David B. Solit
Được phát hành 2011Artigo -
15
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors Bằng Helena Escuin-Ordinas, Shuoran Li, Michael W. Xie, Lu Sun, Willy Hugo, Rong Huang, Jing Jiao, Felipe Meira de‐Faria, Susan Realegeno, Paige Krystofinski, Ariel M. Azhdam, Sara Marie D. Komenan, Mohammad Atefi, Begoña Comı́n-Anduix, Matteo Pellegrini, Alistair J. Cochran, Robert L. Modlin, Harvey R. Herschman, Roger S. Lo, William H. McBride, Tatiana Segura, Antoni Ribas
Được phát hành 2016Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Cancer research
Biology
Cell biology
Melanoma
Gene
Genetics
Medicine
MAPK/ERK pathway
Biochemistry
MEK inhibitor
Mutation
Cancer
Chemistry
Internal medicine
Kinase
Signal transduction
Cell growth
KRAS
Neuroblastoma RAS viral oncogene homolog
Cell culture
Metastatic melanoma
PI3K/AKT/mTOR pathway
Pharmacology
Vemurafenib
Apoptosis
Breast cancer
Cell cycle
Colorectal cancer
Computer science
Cyclin D1